Scott A. Smith
Viatris chief executive officer Scott A. Smith is a deeply knowledgeable senior global biotechnology and
pharmaceutical executive with more than 35 years of experience. He is a seasoned builder who
possesses vast global commercial and pharmaceutical expertise and a proven ability to build, grow and
manage large complex organizations. Before becoming Viatris’ CEO, Smith was President and Chief
Operating Officer of Celgene Corp. Most recently, he served as President of BioAtla, Inc., a global
biotechnology company focused on the development of Conditionally Active BiologicsTM (CAB) antibody
therapeutics. Smith is a member of Viatris board of directors.